SUVENPHAR Suven Pharmaceuticals Ltd Company Mergers Announcement 2024 - Stake Acquisition Suven Pharmaceuticals Ltd has announced the acquisition of a 56% controlling stake in NJ Bio, Inc. for $64.4 million, enhancing its capabilities in the ADC/XDC market which is valued at $2.7 billion and expected to grow over 25% annually..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Suven Pharmaceuticals Ltd